The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...

Demand forweight-loss drugs has grown at an astonishing rate in recent years, driving share prices of healthcare giants such ...

Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop ...

The new weight-loss drugs were originally developed as a treatment for type ... While a tablet form of semaglutide is already available, this was initially approved as a low-dose version that is less ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...